Pfizer Stock News

It's complicated.

It''s complicated.

Japan intends to acquire 145M doses of Moderna (MRNA), and Pfizer (PFE) and BioNTech''s (BNTX) COVID-19 vaccines, Reuters reported citing Kyodo news agency which cited a…

Pfizer and its German partner BioNTech on Tuesday requested emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a second COVID-19 booster dose for seniors. This would be the fourth dose to the regimen of the Pfizer-BioNTech (Pfizer) COVID-19 vaccines for those aged 65 and over. In the United States, the primary […]

Drugmaker Pfizer is expected to request authorisation this week for an additional Covid-19 booster dose for seniors, according to a person familiar with the matter.

Pfizer and BioNTech announced Tuesday they had formally asked the United States drug regulator for emergency approval of a second booster shot of their Covid vaccine for people aged 65 and older.

Hong Kong health experts are hopeful that the recent arrival of two oral Covid-19 drugs, MSD’s molnupiravir and Pfizer’s Paxlovid, can provide a breakthrough in the city’s fight against a fifth wave of infections.The use of oral drugs to treat high-risk Covid-19 patients is among four measures recommended by the University of Hong Kong’s public health experts to reduce severe cases and deaths.The Post examines the two drugs and other treatment options being used in Hong Kong.1. How do the two…

MISE À DAY Pfizer and BioNTech announced on Tuesday that they have asked the United States Medicines Agency to authorize an additional booster dose of their Covid-19 vaccine for people aged 65 and over. This request is made on the basis of data coming from Israel and analyzed at the time the Omicron variant was […] The post Pfizer asks the United States to authorize a second booster dose against COVID-19 first appeared on The Bobr Times .

Pfizer calls for a second reinforced capacity against covid-19 in the United States

Eli Lilly Halts Sales Of All Non-Essential Drugs In Russia Here''s one deprivation the Russian people probably weren''t expecting. American drugmaker Eli Lilly has decided to halt export of all non-essential drugs to Russia, including its blockbuster erectile dysfunction drug, Cialis. The drugmaker told the FT that while it would continue to supply drugs for life-threatening illnesses, it will suspend all marketing, drug trials and investment in Russia, along with all non-essential meds, which they will no longer export. This marks the first time a US drugmaker has decided to pull its business from Russia since the start of the invasion of Ukraine. "For nearly 150 years, Lilly has worked to ensure patients have access to the medicines they need, no matter where they may live," it said in a statement. "Our Russian operations are now only focused on ensuring people suffering from diseases like cancer and diabetes continue to get the Lilly medicines they need." Meanwhile, Pfizer said this week that pausing the flow of its medicines to Russia would violate the company’s foundational principle of "putting patients first" (which…is that what they have been doing with all those price hikes?).

Pfizer''s CEO told "Face the Nation" on Sunday that he believed another booster shot was now "necessary."

The move could further inflame a tortuous debate among scientists over when the coronavirus vaccines’ protection should be bolstered, and for whom.

WASHINGTON (AP) — Pfizer and its partner BioNTech asked U.S. regulators Tuesday to authorize an additional booster dose of their COVID-19 vaccine for seniors, saying data from Israel suggests older adults would benefit. Currently the U.S.

Pfizer and partner BioNTech file application for people 65 years and older

The vaccine makers asked regultors to authorize another booster shot of their Covid-19 vaccine for adults aged 65 and older who have already gotten one booster dose of an approved vaccine.